Literature DB >> 8803949

Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers.

R Kämmerer1, A Iten, P C Frei, P Bürgisser.   

Abstract

CD28 is a transmembrane glycoprotein that provides T cells with an essential co-stimulatory signal during antigen presentation. Using flow cytometry, we document here an expansion of CD28- T cells in HIV infection. Whereas the percentage of CD4+CD28+ T cells among total lymphocytes was decreased, a small increase of the percentage of CD4+CD28- T cells was observed. In the CD8+ subset, there was a marked expansion of CD8+CD28- T cells. An increased percentage of CD8+ T cells positive for HLA-DR was found in both CD28+ and CD28- cells. Results were similar for CD38 expression. HIV infection was also distinguished by a shift from LFA-1lowCD28low to LFA-1highCD28high and LFA-1high-CD28neg expression pattern on CD8+ T cells. Negative correlations were found between percentage and absolute number of CD8+CD28+ T cells and several serum parameters usually associated with poor prognosis (IgA, IgE, beta 2-microglobulin and HIV-1 p24 antigen). Thus, HIV infection is characterized by a marked expansion of CD28- T cells with an abnormal expression of activation markers and cell adhesion molecules. In addition, CD8+CD28+, but not CD8+CD28- or total CD8+ T cell numbers, correlated with the levels of established serological markers of disease severity or progression and may, therefore, have predictive value.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803949     DOI: 10.1007/s004300050010

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

1.  Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.

Authors:  P Bürgisser; C Hammann; D Kaufmann; M Battegay; O T Rutschmann
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.

Authors:  Byeong-Sun Choi; Yong-Keun Park; Joo-Shil Lee
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.

Authors:  L A Trimble; P Shankar; M Patterson; J P Daily; J Lieberman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Neural networks in the assessment of HIV immunopathology.

Authors:  G Hatzakis; C Tsoukas
Journal:  Proc AMIA Symp       Date:  2001

5.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

6.  Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection.

Authors:  Gustavo Olvera-García; Enrique Espinosa; Scott F Sieg; Michael M Lederman
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

Review 7.  Cell proliferation and apoptosis in the immune system in the elderly.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; M P Corsi; D Quaglino
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

8.  Lack of disease specificity limits the usefulness of in vitro costimulation in HIV- and HCV-infected patients.

Authors:  Stefanie Kuerten; Tobias R Schlingmann; Tarvo Rajasalu; Doychin N Angelov; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Clin Dev Immunol       Date:  2008

Review 9.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

10.  Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.

Authors:  Gaurav Kumar; Jacqueline Cottalorda-Dufayard; Rodolphe Garraffo; Francine De Salvador-Guillouët; Eric Cua; Pierre-Marie Roger
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.